This filing is a routine Form 3 and has no immediate trading implications. Monitor for the company's IPO pricing and any subsequent insider trading filings (Form 4) for signals of conviction or selling.
Price Chart
Executive Summary
David Kroin, Deep Track Capital, LP, and Deep Track Biotechnology Master Fund, Ltd. filed a Form 3 initial statement of beneficial ownership for Attovia Therapeutics, Inc. (ATTO). The filing discloses that Deep Track Biotechnology Master Fund, Ltd. holds 1,957,138 shares of common stock and an undisclosed number of Series C Redeemable Convertible Preferred Stock shares, which are convertible at a 9.29-for-one ratio upon the IPO closing. This is a routine initial ownership disclosure by a pre-IPO investor and does not reflect any new trading activity or change in position.
Key Facts
- Form 3 filed by David Kroin, Deep Track Capital, LP, and Deep Track Biotechnology Master Fund, Ltd. for Attovia Therapeutics, Inc.
- Deep Track Biotechnology Master Fund, Ltd. beneficially owns 1,957,138 shares of common stock.
- Deep Track Biotechnology Master Fund, Ltd. also holds Series C Redeemable Convertible Preferred Stock, convertible at 9.29-for-one upon IPO closing.
- This is an initial statement of ownership, not a transaction.
- Attovia Therapeutics is a pre-IPO clinical-stage biotech (SIC 2836).
Financial Impact
No financial impact; this is a routine initial ownership disclosure with no transaction.
Risk Factors
- No material risks identified from this filing; it is a standard initial ownership report.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-333469 |
| Document: 0001193125-26-333469-index.html | 0001193125-26-333469 |
| Document: 0001193125-26-333469.txt | 0001193125-26-333469 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | 3/A | $16.21 | awaiting T+20 | — | $14.39 (−11.23%) |
Oct 8, 2026 18d ago | 3/A | $16.21 | awaiting T+20 | — | $14.39 (−11.23%) |
Sep 28, 2026 28d ago | Press Release | $18.16 | awaiting T+20 | — | $14.39 (−20.76%) |
Sep 2, 2026 7w ago | Press Release | $24.20 $17.14 | ▼ −29.17% | ▼ −28.06% | $14.39 (−40.54%) |
Aug 28, 2026 8w ago | 144 / CLUSTER | $21.40 $18.16 | ▼ −15.14% | ▼ −14.95% | $14.39 (−32.76%) |
Aug 13, 2026 10w ago | Insider Buy | $19.86 $24.52 | ▲ +23.46% | ▲ +25.46% | $14.39 (−27.54%) |
Aug 13, 2026 10w ago | Insider Cluster | $19.86 $24.52 | ▲ +23.46% | ▲ +25.46% | $14.39 (−27.54%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.65 $22.86 | ▲ +22.57% | ▲ +23.63% | $14.39 (−22.84%) |
Aug 7, 2026 11w ago | Insider Cluster | $19.84 $23.66 | ▲ +19.25% | ▲ +20.17% | $14.39 (−27.47%) |
Aug 7, 2026 11w ago | Insider Cluster | $20.17 $25.55 | ▲ +26.67% | ▲ +27.07% | $14.39 (−28.66%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers